Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from the sovleplenib ESLIM-01 Phase III trial, as well as several investigator-initiated studies of compounds ...

Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should spark some buyer’s delight. | Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should ...

In a world where medical advancements often steal the spotlight, one act of kindness continues to save lives in profound ways ...

Panic surrounding dengue or chikungunya and many new testing centres having come up in the state capital - diaognosing more ...